| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL AND ETHINYL ESTRADIOL | 49 |
| 1 | PREDNISONE | 44 |
| 2 | ADALIMUMAB | 40 |
| 3 | COPPER | 36 |
| 4 | ALENDRONATE SODIUM | 29 |
| 5 | ETONOGESTREL | 29 |
| 6 | PANTOPRAZOLE | 27 |
| 7 | NATALIZUMAB | 26 |
| 8 | AMBRISENTAN | 25 |
| 9 | MONTELUKAST SODIUM | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 15 | 0.0054 |
| 1 | ACLIDINIUM BROMIDE | 19 | 0.0030 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL | 49 | 0.0022 |
| 3 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| 4 | THEOPHYLLINE ANHYDROUS | 19 | 0.0015 |
| 5 | PENICILLIN G BENZATHINE | 2 | 0.0015 |
| 6 | COAL TAR | 1 | 0.0013 |
| 7 | IPTACOPAN | 1 | 0.0013 |
| 8 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | 1 | 0.0012 |
| 9 | MERCAPTOPURINE | 18 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 90 |
| 1 | Corticosteroid [EPC] | 55 |
| 2 | Estrogen [EPC] | 55 |
| 3 | Endothelin Receptor Antagonist [EPC] | 41 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 5 | Benzodiazepine [EPC] | 37 |
| 6 | Copper-containing Intrauterine Device [EPC] | 36 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 8 | Proton Pump Inhibitor [EPC] | 35 |
| 9 | Vitamin D [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Copper-containing Intrauterine Device [EPC] | 36 | 0.0007 |
| 2 | Oxytocic [EPC] | 2 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 4 | Methylxanthine [EPC] | 22 | 0.0004 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 9 | 0.0003 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Integrin Receptor Antagonist [EPC] | 27 | 0.0003 |
| 8 | Progestin [EPC] | 90 | 0.0003 |
| 9 | Estrogen [EPC] | 55 | 0.0003 |